Regulus Therapeutics

$1.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-7.38%) Today
-$0.01 (-0.72%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RGLS and other stocks, options, and ETFs commission-free!

About RGLS

Regulus Therapeutics Inc. Common Stock, also called Regulus Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs.

CEO
Joseph P. Hagan
Employees
24
Headquarters
San Diego, California
Founded
2007
Market Cap
99.39M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
780.32K
High Today
$1.49
Low Today
$1.36
Open Price
$1.46
Volume
695.41K
52 Week High
$2.32
52 Week Low
$0.4222

RGLS Earnings

-$0.26
-$0.17
-$0.09
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, After Hours

You May Also Like

DFS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure